KELLY GOLDEN: Open Payments
NPI 1902939655 · WINCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,203 in 132 payments from 35 companies in 2025. Trend: 2023 $2,520 · 2024 $2,625 · 2025 $3,203
Food & beverage: $2,928Education: $275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $422 |
| Regeneron Healthcare Solutions, Inc. | 30 | $403 |
| Merck Sharp & Dohme LLC | 13 | $384 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $239 |
| JAZZ PHARMACEUTICALS INC. | 6 | $224 |
| Daiichi Sankyo Inc. | 4 | $161 |
| GENZYME CORPORATION | 5 | $126 |
| Astellas Pharma US Inc | 3 | $120 |
| SEAGEN INC. | 1 | $100 |
| Genmab U.S., Inc. | 4 | $99 |
Products named: LIBTAYO, KEYTRUDA, Enhertu, TAGRISSO, ZIIHERA, SARCLISA, Epkinly, ZEPZELCA.
Industry payments across TN — which companies pay providers there.
